Critical evaluation of agents used in the treatment and prevention of cytomegalovirus infection in immunocompromised patients.
Meyers
J D
JD
Program in Infectious Diseases, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.
D016026:Bone Marrow Transplantation / Q000276:immunology*; D003586:Cytomegalovirus Infections / Q000188:drug therapy / Q000517:prevention & control / Q000628:therapy*; D015774:Ganciclovir / Q000627:therapeutic use*; D006801:Humans; D007116:Immunization, Passive; D007165:Immunosuppression Therapy; D011014:Pneumonia / Q000209:etiology / Q000628:therapy
D015774:Ganciclovir